Appili Therapeutics Inc (APLI : TSX)
Common Stock
$0.01
CAD
+0.00 (50.00%)
Last updated: 2026-07-30
Get APLI alerts:
APLI
Appili Therapeutics Inc
Performance
1 Day
+50.00%
1 Week
+50.00%
1 Month
+0.00%
YTD
-40.00%
Key Statistics
Market Cap
$1.32M
52W High
$0.04
52W Low
$0.01
P/E Ratio
-
50 Day MA
$0.01
200 Day MA
$0.02
Beta
-0.21
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 7/30/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 2,500 |
| 7/22/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 239,050 |
| 7/10/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 7,002 |
| 7/9/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 300,000 |
| 7/7/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 64,000 |
| 7/3/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 0 |
| 7/2/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 58,300 |
| 6/30/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 25,000 |
| 6/29/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 37,010 |
| 6/26/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 0 |
Analyst Price Targets
Based on analyst covering APLI
Wall Street analysts forecast APLI stock price to rise 900.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.15
+900.0% Upside
Current Price
C$0.01
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on APLI's historical volatility
30-Day Vol
207.3%
Annualized
90-Day Vol
222.9%
Annualized
Trend (90d)
+0.0%
Annualized drift
90d Mean
C$0.02
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$0.02 | C$0.01 โ C$0.03 |
| 60 trading days | C$0.02 | C$0.01 โ C$0.04 |
| 90 trading days | C$0.02 | C$0.00 โ C$0.05 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Appili Therapeutics Inc
Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of treatments targeting unmet needs in infectious diseases in the United States and Canada. The company offers LIKMEZ (ATI-1501), a liquid oral taste-masked reformulation of the antibiotic metronidazole to treat anaerobic bacterial and protozoal infections. It also develops ATI-1801, a topical formulation of paromomycin in a Phase III trial for the treatment of cutaneous leishmaniasis; and ATI-1701, a live-attenuated vaccine in preclinical trials for the prevention of Francisella tularensis infection. The company has a collaboration with Vitalex Biosciences to advance VXV-01, a dual-antigen vaccine targeting invasive Candida infections. Appili Therapeutics Inc. was incorporated in 2015 and is headquartered in Halifax, Canada.
Financials
- Revenue (TTM)
- $244,179
- EBITDA
- $-6.52M
- Profit Margin
- 0.00%
- ROE (TTM)
- -938.72%
- EPS (Diluted)
- -0.03
- Book Value
- -0.13
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About APLI
Market movers
Recent TSX movers
Top 1-day gainers โ updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| BHC | Bausch Health Companies Inc | $8.43 | +28.51% |
| KEEL | Keel Infrastructure Corp. | $5.64 | +26.74% |
| HUT | Hut 8 Mining Corp | $151.68 | +22.39% |
| HIVE | HIVE DIGITAL TECHNOLOGIES LTD | $4.21 | +18.59% |
| IVQ | Invesque Inc | $0.14 | +17.39% |
| S | Sherritt International Corporation | $0.14 | +16.67% |
| PNC-A | Postmedia Network Canada Corp | $0.99 | +16.47% |
| SAM | Starcore International Mines Ltd | $0.45 | +13.92% |
APLI.TO news timeline
7 articles covering APLI.TO, most recent first
LatestWhat's Going On With Appili Therapeutics Inc Stock Monday?
July 2026
- Why Appili Therapeutics Inc stock is plummeting today
- Why Appili Therapeutics Inc stock is plummeting today
- What's Going On With Appili Therapeutics Inc Stock Monday?
- What's Going On With Appili Therapeutics Inc Stock Monday?
- Why Appili Therapeutics Inc stock is plummeting today
- Why Appili Therapeutics Inc stock is plummeting today